Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-31 Purchase | 2022-05-31 5:13 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 28,000 | $0.18 | $5,040 | 148,319 (Direct) | View |
| 2022-03-03 Purchase | 2022-03-09 4:03 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 76,246 | $0.391 | $29,812 | 110,319 (Direct) | View |
| 2020-08-17 Purchase | 2020-08-18 08:35 am | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 5,000 | $1 | $5,000 | 12,000 (Direct) | View |
| 2020-02-19 Purchase | 2020-02-20 4:07 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 2,000 | $0.95 | $1,900 | 7,000 (Direct) | View |
| 2020-02-13 Purchase | 2020-02-13 5:57 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 5,000 | $0.859 | $4,295 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-20 Option Award | 2024-02-22 4:37 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 6,432 | $0 | 21,851 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:35 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 8,000 | $0 | 15,419 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-12-12 6:29 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 1,488 | $1.734 | 7,419 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-11-08 5:40 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,314 | $1.734 | 13,245 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-07 4:33 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,314 | $1.734 | 155,633 (Direct) | View |
| 2022-05-03 Option Award | 2022-05-05 4:03 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 10,000 | $0.1863 | 120,319 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-21 4:03 pm | N/A 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-11-03 Option Award | 2021-11-05 2:54 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,787 | $0.718 | 34,073 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 5:11 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 9,563 | $0.567 | 26,286 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-04 5:02 pm | N/A 2030-12-01 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-11-03 Option Award | 2020-11-05 5:42 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 4,723 | $0.561 | 16,723 (Direct) | View |
| 2020-07-14 Option Award | 2020-07-16 8:55 pm | N/A 2030-07-13 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 49,955 | $0 | 49,955 (Direct) | View |
| 2020-03-23 Option Award | 2020-03-25 6:03 pm | N/A 2030-03-22 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 30,000 | $0 | 30,000 (Direct) | View |